| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 18.3 | 12.0 | 11.3 |
| Other income | 0.1 | 0.3 | 0.2 |
| Total income | 18.5 | 12.3 | 11.5 |
| Profit before exceptional items & tax | 2.0 | 1.9 | 1.2 |
| Exceptional items | 0.0 | 0.0 | 0.3 |
| Profit before tax | 2.0 | 1.9 | 1.6 |
| Net profit | 1.5 | 1.4 | 1.2 |
| Operating margin | 10.8% | 15.4% | 13.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +25.00% |
|---|---|
| Net profit, quarter on quarter | +7.10% |
| Revenue, year on year | +61.90% |
Source
Read the filing ↗
BSE results filing, BSE: 540204. Figures extracted from the filing.
Eiko Lifesciences Ltd: key numbers
- Share price
- ₹51.22
- Market cap
- ₹70.28 Cr
- Revenue (annual)
- ₹52.57 Cr
- Net profit (annual)
- ₹4.50 Cr
- P/E (TTM)
- 14.4×Sector 37.5×
- Promoter holding
- 39.91%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eiko Lifesciences Ltd
All →
18:54 IST
BSE
Annual General Meeting
Eiko Lifesciences Annual General Meeting
Eiko LifeSciences held its 49th Annual General Meeting on September 22, 2026. The meeting transacted business, including adoption of financial statements and appointment of directors.
13:49 IST
BSE
Financial Results
Eiko Lifesciences Q1 FY27 Results: Net Profit ₹1.5 Cr, Up 36.4% YoY
Eiko Lifesciences Ltd reported revenue from operations of ₹16.7 Cr (+56.1% YoY) and net profit of ₹1.5 Cr (+36.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.5 Cr · +36.4% YoY